Cargando…
Recent Findings on Cell-Based Therapies for COVID19-Related Pulmonary Fibrosis
COVID-19 has spread worldwide, including the United States, United Kingdom, and Italy, along with its site of origin in China, since 2020. The virus was first found in the Wuhan seafood market at the end of 2019, with a controversial source. The clinical symptoms of COVID-19 include fever, cough, an...
Autores principales: | Chuang, Hong-Meng, Ho, Li-Ing, Harn, Horng-Jyh, Liu, Ching-Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047934/ https://www.ncbi.nlm.nih.gov/pubmed/33845643 http://dx.doi.org/10.1177/0963689721996217 |
Ejemplares similares
-
Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis: Improvement with Target Combination
por: Chuang, Hong-Meng, et al.
Publicado: (2018) -
The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
por: Chuang, Hong-Meng, et al.
Publicado: (2019) -
Differentiation of Human Pluripotent Stem Cells Into Specific
Neural Lineages
por: Chang, Chia-Yu, et al.
Publicado: (2021) -
Non-Canonical Regulation of Type I Collagen through Promoter Binding of SOX2 and Its Contribution to Ameliorating Pulmonary Fibrosis by Butylidenephthalide
por: Chuang, Hong-Meng, et al.
Publicado: (2018) -
The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration
por: Chuang, Hong-Meng, et al.
Publicado: (2016)